子宫肌瘤自发性破裂出血致失血性休克1例并文献复习
A Case of Hemorrhagic Shock Due to Spontaneous Rupture and Bleeding of Uterine Fibroids and Literature Review
DOI: 10.12677/acm.2025.152537, PDF,   
作者: 刘 婷, 陈卓琳:西安医学院研工部,陕西 西安;吴桂清*:陕西省人民医院产科,陕西 西安
关键词: 子宫肌瘤自发性破裂腹腔内出血失血性休克Uterine Fibroids Spontaneous Rupture Intraperitoneal Hemorrhage Hemorrhagic Shock
摘要: 子宫肌瘤是女性生殖系统中最常见的良性肿瘤,发病率约为4.5%~68.6%,近期有研究证实其发病率甚至高达70%~80%。约30%的子宫肌瘤患者可出现临床症状,主要包括异常子宫出血、周围器官压迫症状、盆腔疼痛、不孕及产科并发症等。子宫肌瘤的急性并发症很少见,包括有肌瘤蒂扭转、变性和破裂出血,而子宫肌瘤自发性破裂引起腹腔内出血是一种非常罕见的表现。大多数发生在育龄妇女中,患者突然出现严重腹痛和严重低血容量休克,需要紧急手术干预。尽管医学影像技术不断进步,但术前诊断仍常被漏诊。在此,本文报道了一例子宫肌瘤自发性破裂出血导致休克的患者,并探讨其诊断和治疗策略,旨在为临床诊断和治疗提供参考。
Abstract: Uterine fibroids are the most common benign tumours in the female reproductive system, with a prevalence of about 4.5~68.6 percent, and recent studies have confirmed that their prevalence is even as high as 70~80 percent. About 30% of patients with uterine fibroids may present clinical symptoms, mainly including abnormal uterine bleeding, symptoms of peripheral organ compression, pelvic pain, infertility and obstetric complications. Acute complications of fibroids are rare and include fibroid tip torsion, degeneration and rupture and bleeding, while spontaneous rupture of fibroids causing intra-abdominal haemorrhage is a very rare presentation. Mostly it occurs in women of childbearing age, where the patient presents suddenly with severe abdominal pain and severe hypovolaemic shock, requiring urgent surgical intervention. Despite advances in medical imaging technology, preoperative diagnosis is still often missed. Herein, we report a case of spontaneous rupture of uterine fibroid with bleeding leading to shock and discuss the diagnostic and therapeutic strategies, aiming to provide reference for clinical diagnosis and treatment.
文章引用:刘婷, 陈卓琳, 吴桂清. 子宫肌瘤自发性破裂出血致失血性休克1例并文献复习[J]. 临床医学进展, 2025, 15(2): 1786-1791. https://doi.org/10.12677/acm.2025.152537

参考文献

[1] Yang, Q., Ciebiera, M., Bariani, M.V., Ali, M., Elkafas, H., Boyer, T.G., et al. (2021) Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocrine Reviews, 43, 678-719. [Google Scholar] [CrossRef] [PubMed]
[2] 甄珠, 张刘, 丹华, 等. 子宫肌瘤的发病机制和治疗[J]. 中国药物与临床, 2022, 22(7): 665-669.
[3] Donnez, J. and Dolmans, M. (2016) Uterine Fibroid Management: From the Present to the Future. Human Reproduction Update, 22, 665-686. [Google Scholar] [CrossRef] [PubMed]
[4] Sabry, M. and Al-Hendy, A. (2012) Innovative Oral Treatments of Uterine Leiomyoma. Obstetrics and Gynecology International, 2012, Article ID: 943635. [Google Scholar] [CrossRef] [PubMed]
[5] Reis, F.M., Bloise, E. and Ortiga-Carvalho, T.M. (2016) Hormones and Pathogenesis of Uterine Fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology, 34, 13-24. [Google Scholar] [CrossRef] [PubMed]
[6] Ahmad, A., Kumar, M., Bhoi, N.R., Badruddeen, Akhtar, J., Khan, M.I., et al. (2023) Diagnosis and Management of Uterine Fibroids: Current Trends and Future Strategies. Journal of Basic and Clinical Physiology and Pharmacology, 34, 291-310. [Google Scholar] [CrossRef] [PubMed]
[7] Gupta, S. and Manyonda, I.T. (2009) Acute Complications of Fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology, 23, 609-617. [Google Scholar] [CrossRef] [PubMed]
[8] Sethupathy, T., Madathupalayam, M. and Arun Prasad, K. (2022) Intra-Abdominal Hemorrhagic Catastrophe Due to Large Subserous Myomatous Capsular Venous Rupture. Case Reports in Obstetrics and Gynecology, 2022, Article ID: 2696213. [Google Scholar] [CrossRef] [PubMed]
[9] Lim, W.H., Cohen, S.C. and Lamaro, V.P. (2020) Intra-Abdominal Haemorrhage from Uterine Fibroids: A Systematic Review of the Literature. BMC Surgery, 20, Article No. 70. [Google Scholar] [CrossRef] [PubMed]
[10] Takaki, E., Goto, M., Hori, K. and Ito, K. (2021) Hypovolaemic Shock Due to Intra-Abdominal Haemorrhage from Multiple Uterine Fibroids. BMJ Case Reports, 14, e241782. [Google Scholar] [CrossRef] [PubMed]
[11] Mattison, D.R. and Yeh, S.Y. (1980) Hemoperitoneum from Rupture of a Uterine Vein Overlying a Leiomyoma. American Journal of Obstetrics and Gynecology, 136, 415-416. [Google Scholar] [CrossRef] [PubMed]
[12] Kaganov, H. and Ades, A. (2016) Uterine Fibroids: Investigation and Current Management Trends. Australian Family Physician, 45, 722-725.
[13] 顾金娟. 经腹与经阴道超声对子宫肌瘤的临床诊断价值[J]. 影像研究与医学应用, 2021, 5(4): 151-152.
[14] 苏萍, 李力, 肖进, 等. 磁共振成像技术在诊断与治疗子宫肌瘤中的临床价值[J]. 中国计划生育和妇产科, 2019, 11(8): 24-26.
[15] 吴静. 子宫肌瘤的MRI检查与诊断作用研究[J]. 首都食品与医药, 2018, 25(19): 46-47.
[16] Micić, J., Macura, M., Andjić, M., Ivanović, K., Dotlić, J., Micić, D.D., et al. (2024) Currently Available Treatment Modalities for Uterine Fibroids. Medicina, 60, Article 868. [Google Scholar] [CrossRef] [PubMed]
[17] Kuznetsova, M.V., Tonoyan, N.M., Trubnikova, E.V., Zelensky, D.V., Svirepova, K.A., Adamyan, L.V., et al. (2023) Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids. Diseases, 11, Article 156. [Google Scholar] [CrossRef] [PubMed]
[18] 叶明珠, 薛敏. 子宫肌瘤微无创治疗的适应证和禁忌证[J]. 中国实用妇科与产科杂志, 2024, 40(9): 886-891.
[19] Althobaiti, F.A., Alsaadi, K.K. and Althobaiti, A.A. (2019) A Case of Hemoperitoneum Due to Spontaneous Bleeding from a Uterine Leiomyoma. American Journal of Case Reports, 20, 167-170. [Google Scholar] [CrossRef] [PubMed]
[20] 娄诤, 李春明, 周坚红. 子宫肌瘤病因与预防[J]. 实用妇产科杂志, 2024, 40(2): 81-84.